[1]Duh EJ, Sun JK, Stitt AW. Diabetic retinopathy: current understanding, mechanisms, and treatment strategies[J]. JCI Insight, 2017, 2(5): e93751.
[2]Stitt AW, Curtis TM, Chen M, et al. The progress in understanding and treatment of diabetic retinopathy [J]. Prog Retin Eye Res, 2016, 51(7): 156-186.
[3]Antonetti DA, Klein R, Gardner TW. Diabetic retinopathy[J]. N Engl J Med, 2012, 366(4): 1227-1239.
[4]Yau JW, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy [J]. Diabetes Care, 2012, 35(7): 556-564.
[5]Datta S, Cano M, Ebrahimi K, et al. The impact of oxidative stress and inflammation on RPE degeneration in non-neovascular AMD [J]. Prog Retin Eye Res, 2017, 60(7): 201-218.
[6]Tien T, Barrette KF, Chronopoulos A, et al. Effects of high glucose-induced Cx43 downregulation on occludin and ZO-1 expression and tight junction barrier function in retinal endothelial cells [J]. Invest Ophthalmol Vis Sci, 2013, 54(8): 6518-6525.
[7]Garcia-Medina JJ, Monica d-R-V, Garcia-Medina M, et al. Chapter 4-diabetic retinopathy and oxidative stress. In: Preedy VR, editor. Diabetes: Oxidative Stress and Dietary Antioxidants [M]. San Diego: Academic Press; 2014. p. 33-40.
[8]Lutty GA. Effects of diabetes on the eye [J]. Invest Ophthalmol Vis Sci, 2013, 54(8): 81-87.
[9]宋娟, 田小霞, 李宝红, 等. 白藜芦醇对去卵巢骨质疏松大鼠Wnt/β-Catenin通路的影响[J]. 中国临床药理学与治疗学, 2017, 22(5): 138-141.
[10]Zhou C, Ding J, Wu Y. Resveratrol induces apoptosis of bladder cancer cells via miR 21 regulation of the Akt/Bcl 2 signaling pathway [J]. Mol Med Rep, 2014, 9(4): 1467-1473.
[11]Noh KT, Chae SH, Chun SH, et al. Resveratrol suppresses tumor progression via the regulation of indoleamine 2,3-dioxygenase[J]. Biochem Biophys Res Commun, 2013, 431(2): 348-353.
[12]Sareen D, van Ginkel PR, Takach JC, et al. Mitochondria as the primary target of resveratrol-induced apoptosis in human retinoblastoma cells [J]. Invest Ophthalmol Vis Sci, 2006, 47(9): 1132-1144.
[13]杨影, 吴峥峥, 程依琏, 等. 白藜芦醇对过氧化氢诱导人视网膜色素上皮细胞凋亡的保护作用[J]. 实用医学杂志, 2018, 34(8): 1244-1247.
[14]Shi H, Zhang Z, Wang X, et al. Inhibition of autophagy induces IL-1beta release from ARPE-19 cells via ROS mediated NLRP3 inflammasome activation under high glucose stress [J]. Biochem Biophys Res Commun, 2015, 463(7): 1071-1076.
[15]Mondal A, Bennett LL. Resveratrol enhances the efficacy of sorafenib mediated apoptosis in human breast cancer MCF7 cells through ROS, cell cycle inhibition, caspase 3 and PARP cleavage [J]. Biomed Pharmacother, 2016, 84(7): 1906-1914.
[16]Liu WY, Liou SS, Hong TY, et al. Hesperidin prevents high glucose-induced damage of retinal pigment epithelial cells [J]. Planta Med, 2018, 31(7): 1209-1216.
[17]Liu J, Zhang C, Hu W, et al. Tumor suppressor p53 and its mutants in cancer metabolism [J]. Cancer Lett, 2015, 356(7): 197-203.
[18]Galanos P, Vougas K, Walter D. Chronic p53-independent p21 expression causes genomic instability by deregulating replication licensing [J]. Nature, 2016, 18(7): 777-789.
[19]Sharma S, Saxena S, Srivastav K, et al. Nitric oxide and oxidative stress is associated with severity of diabetic retinopathy and retinal structural alterations [J]. Clin Exp Ophthalmol, 2015, 43(6): 429-436.
[20]Lopez MS, Dempsey RJ, Vemuganti R, et al. Resveratrol preconditioning induces cerebral ischemic tolerance but has minimal effect on cerebral microRNA profiles [J]. J Cereb Blood Flow Metab, 2016, 36(9): 201-213.
[21]Xu XH, Ding DF, Yong HJ, et al. Resveratrol transcriptionally regulates miRNA- 18a- 5p expression ameliorating diabetic nephropathy via increasing autophagy[J]. Eur Rev Med Pharmacol Sci, 2017, 21(21): 109-116.
[22]Gracia A, Fernández-Quintela A, Miranda J, et al. Are miRNA-103,miRNA-107 and miRNA-122 involved in the prevention of liver steatosis induced by resveratrol[J]. Nutrients, 2017, 9(4): 209-216.
[23]Gong Y, Wu W, Zou X, et al. MiR-26a inhibits thyroid cancer cell proliferation by targeting ARPP19 [J]. Am J Cancer Res, 2018, 8(4): 1030-1039.
[24]Buckner CA, Buckner AL, Koren SA, et al. Exposure to a specific time-varying electromagnetic field inhibits cell proliferation via cAMP and ERK signaling in cancer cells [J]. Nutrients, 2018, 39(9): 217-230.
[25]Liu Y, Li X, Jiang S, et al. Tetramethylpyrazine protects against high glucose-induced vascular smooth muscle cell injury through inhibiting the phosphorylation of JNK, p38MAPK, and ERK[J]. J Cereb Blood Flow Metab, 2018, 46(7): 3318-3326.
[26]Garcia-Jimenez C, Garcia-Martinez JM, Chocarro-Calvo A, et al. A new link between diabetes and cancer: enhanced WNT/beta-catenin signaling by high glucose [J]. J Mol Endocrinol, 2014, 52(7): R51-66. |